XW1437ATransfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10
- Billable / Specific Code
XW1437A is a billable ICD-10-PCS procedure code for Transfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRGs 016, 017. The root operation Transfusion involves putting in blood or blood products.
Code Identity
PCS Table Breakdown
Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.
| Position | Designation | Value | Meaning |
|---|---|---|---|
| 1 | Section | X | New Technology |
| 2 | Body System | W | Anatomical Regions |
| 3 | Operation | 1 | Transfusion |
| 4 | BodyPart | 4 | Central Vein |
| 5 | Approach | 3 | Percutaneous |
| 6 | Device/Substance/Technology | 7 | Marnetegragene Autotemcel |
| 7 | Qualifier | A | New Technology Group 10 |
Code History
- 30243C0 — Transfuse Autol HSPC, Gene Mod in Central Vein, Perc
Similar Procedure Codes
Questions About XW1437A
Is XW1437A a billable code?
Yes. XW1437A is a complete seven-character ICD-10-PCS code, specific enough to report Transfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10 on inpatient claims from October 1, 2025 through September 30, 2026.
What do the characters in XW1437A mean?
XW1437A breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 1 is the Operation (Transfusion); the 4th character 4 is the BodyPart (Central Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character 7 is the Device/Substance/Technology (Marnetegragene Autotemcel); the 7th character A is the Qualifier (New Technology Group 10).
What MS-DRG does XW1437A group to?
On an inpatient stay, Transfusion of Marnetegragene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 10 maps to MS-DRGs 016, 017, with relative weights from 4.8383 to 5.9297. The MS-DRG sets the fixed Medicare payment for the stay.
